Free shipping on all orders over $ 500

α-cyano-4-hydroxy-cinnamic acid

Cat. No. M9202
α-cyano-4-hydroxy-cinnamic acid Structure
Synonym:

ACCA; α-CHCA

Size Price Availability Quantity
100mg USD 77  USD77 In stock
200mg USD 97  USD97 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

α-CHCA is a classic monocarboxylate transporters (MCT) inhibitor. In the sensitive U251 cells, CHCA is able to inhibit cell proliferation and induce cell death, having a cytotoxic effect; however, in the less sensitive SW1088 cells, CHCA only inhibits cell proliferation but did not induce cell death. Transport by MCT1, 2, and 4 is competitively inhibited by CHCA whereas transport by MCT3 is insensitive to α-cyano-4-hydroxy-cinnamic acid.

Chemical Information
Molecular Weight 189.17
Formula C10H7NO3
CAS Number 28166-41-8
Solubility (25°C) DMSO: ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Miranda-Goncalves V, et al. Neuro Oncol. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.

[2] Sonveaux P, et al. J Clin Invest. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.

Related Monocarboxylate Transporter (MCT) Products
AZD0095 

AZD0095 is a selective and orally active MCT4 inhibitor (IC50: 1.3 nM). AZD0095 effectively inhibits the tumor growth in NCI-H358 xenograft in combination with Cediranib.

MSC-4381

MSC-4381 (MCT4-IN-1) is an orally active and selective monocarboxylate transporter 4 (MCT4/SLC16A3) inhibitor with an IC50 of 77 nM and a Ki of 11 nM. MSC-4381 targets to the cytosolic domain of MCT4. MSC-4381 results in lactate efflux inhibition and reduction of cellular viability in MCT4 high expressing cells. MSC-4381 has the potential for MCT4 transporter inhibition research.

MCT1-IN-2 

MCT1-IN-2 is a potent monocarboxylate transporter 1 (MCT1) inhibitor. MCT1-IN-2 has anti-cancer activity.

VB124 

VB124 is an orally active, potent, and selective MCT4 inhibitor. VB124 can specifically inhibit lactate efflux with IC50s of 8.6 nM and 19 nM for lactate import and export in MDA-MB-231 cells, respectively. VB124 is highly selective for MCT4 over MCT1. VB124 can be used for the research of cardiac hypertrophy, heart failure, and metabolism.

BAY-8002

BAY-8002 is a potent, selective, orally active inhibitor of monocarboxylate transporter 1 (MCT1), with an IC50 of 85 nM in the MCT1-expressing DLD-1 cells, displays excellent selectivity against MCT4. Anti-tumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: α-cyano-4-hydroxy-cinnamic acid, ACCA; α-CHCA supplier, Monocarboxylate Transporter (MCT), inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.